The upside case is not a moonshot
TAM claim. Cerence already has real distribution, high
gross margins, low
capex, and improving cash generation; the question is whether
xUI moves from launch narrative to repeatable production economics. If that happens, investors can pay somewhat more for each dollar of revenue, but not a full AI-platform premium because OEMs still hold bargaining power.